Back to Journals » Drug Design, Development and Therapy » Volume 13

Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy

Total article views   HTML views PDF downloads Totals
10,123 Dovepress* 6,717+ 1,498 8,215
PubMed Central* 3,406 784 4,190
Totals 10,123 2,282 12,405
*Since 8 February 2019

View citations on PubMed Central and Google Scholar